EU-OPENSCREEN will host a workshop prior to the opening of BIOPROSP_23, on 14 March from 09.00 to 12.00. All participants at BIOPROSP_23 can attend the workshop, but there is a maximum capacity of 55 participants.
Please opt for "Pre-conference workshop" as an add-on in the registry form for the conference. The add-on appears after you have chosen one of the Event fees.
Thanks to their molecular complexity and collective scaffold diversity, bioactive natural products represent a valuable source for drug discovery efforts. However, only a fraction of reported scaffolds are available in commercial libraries and access to HTS-amenable libraries remains an important challenge. During this pre-conference EU-OPENSCREEN workshop, we will discuss how publicly available repositories, local bioprospecting efforts and research infrastructures can help expand the availability of high quality, well annotated natural product-based libraries for screening. Our speakers will present publicly available resources in Europe, which are available to the research community; local efforts in bioprospecting and creating local collections; and collaborative initiatives to expose natural compounds to a broad range of biological targets in screening efforts.
- Jeanette Andersen, University of Tromsø
- Bahne Stechmann, EU-OPENSCREEN
- Welcome and Introduction. Jeanette Andersen, University of Tromsø
- EU-OPENSCREEN: A multinational initiative to support collaborative projects in chemical biology. Bahne Stechmann, EU-OPENSCREEN
- Marine natural products bioprospecting and collaboration opportunities at EU-OPENSCREEN. Olga Genilloud, Fundación MEDINA
- Marine natural products - challenges and opportunities for HTS discoveries. Päivi Tammela, University of Helsinki
- Exploring the chemical and biological potential of marine organisms through metabolomics and chemical biology. Mark Brönstrup, HZI Braunschweig
- Natural Products as Drug Candidates and Targeted Modulators of the Immune System. Angelo Fontana, ICB-CNR Naples
- Expanding the chemical space of ribosomal peptide natural products. Jörn Piel, ETH
- Improving clinical trial outputs – the need for comprehensive compound profiling of potential drug molecules. Sheraz Gul, Fraunhofer ITMP
- Creation and screening of natural product libraries from an industrial point of view. Karsten Siems, AnalytiCon Discovery